RxSight (RXST) Change in Inventory (2020 - 2026)

RxSight (RXST) has 7 years of Change in Inventory data on file, last reported at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 111.02% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.3 million (up 154.9% YoY), and the FY2025 full-year result was $11.5 million, up 129.96% from the prior year.
• Change in Inventory for Q1 2026 stood at $3.4 million, up from $3.2 million in the prior quarter.
• Across five years, Change in Inventory topped out at $4.0 million in Q3 2022 and bottomed at -$1.4 million in Q4 2023.
• The 5-year median for Change in Inventory is $1.6 million (2025), against an average of $1.8 million.
• The widest annual swing landed in 2023, when Change in Inventory plunged 566.01%; it then jumped 782.91% in 2024.
• A 5-year view of Change in Inventory shows it stood at -$203000.0 in 2022, then slumped by 566.01% to -$1.4 million in 2023, then surged by 130.18% to $408000.0 in 2024, then surged by 690.44% to $3.2 million in 2025, then climbed by 4.5% to $3.4 million in 2026.
• The last three Change in Inventory figures came in at $3.4 million (Q1 2026), $3.2 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.

Peer Comparison